Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
Clinical trial NCT00494442 · COMPLETED
Trial details
- NCT number
- NCT00494442
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-11
- Primary completion
- 2009-03-17
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.